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Abstract
Objective
This nation-wide register-based study investigated how often substance use disorders
(SUD) and co-morbid disorders occurred in affected families compared to control families.
Method
A total of N = 2504 child and adolescent psychiatric participants who were born between
1969 and 1986 and were registered in the Danish Psychiatric Central Research Register
(DPCRR) had a mental disorder before the age of 18 and developed SUD at some point dur-
ing their life-time. In addition, N = 7472 controls without any psychiatric diagnosis before age
18 and matched for age, sex, and residential region were included. Psychiatric diagnoses of
the first-degree relatives were also obtained. A family load component was assessed.
Results
SUD occurred significantly more often in case families than in control families. SUD risk fac-
tors included SUD, depression, anxiety disorders, personality disorders, or conduct disor-
ders in the family. Furthermore, male sex, more recent year of birth, and living in the capital
city of Copenhagen were also significantly associated with having SUD. The family load
explained 30% of the SUD manifestation in the case-probands. The findings in the total
SUD group were mostly replicated in the two major subgroups of pure alcohol or multiple
substance use disorders.
Discussion
These findings based on a very large and representative dataset provide additional evi-
dence for the strong family aggregation and further risk factors in SUD. The pattern of risk
factors is largely the same for the total group of SUD and the major subgroups of pure alco-
hol and multiple substance use disorders.
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Introduction
The risk of substance use disorders (SUD) in relatives of individuals with SUD has been exam-
ined in various family-based studies. It is well established that, compared to control-probands,
first-degree relatives of case-probands have elevated rates of alcohol abuse or dependence [1,
2], or an increased risk of drug disorders across the range of various substances [3–7]. In addi-
tion, various studies point to specificity of familial aggregation of the predominant drug of
abuse [3, 7] suggesting that there may be risk factors both specific to particular substances and
to SUD in general.
In addition, several investigations have shown that there is a high chance of having comor-
bid mental disorders in the offspring of parents with SUD including anxiety disorders [1, 8],
depressive disorders [1], externalizing disorders [9], or any mental disorder [10]. Irrespective
of family studies, the comorbidity of alcoholism with anxiety and depressive disorders has
been also documented with strong cross-site consistency in four geographic communities
[11]. Another epidemiological study showed that in late adolescence and young adulthood
heavy and problematic use of alcohol co-occurs with both internalizing and externalizing
problems [12]. Also in the relatives of probands selected for alcoholism, there is an association
of alcoholism with anxiety disorders [1, 13], and it has been shown that first-degree relatives of
ADHD probands were at elevated risk for SUD compared with relatives of control subjects
[14].
Taking the opposite perspective, there is also evidence that various other clinical disorders
frequently co-occur with SUD. This has been shown for the eating disorders with a subgroup
of patients with bulimic features displaying comorbid substance abuse [15, 16]. According to a
recent study in adults, the association between various childhood externalizing disorders and
later substance use is strongest for childhood conduct disorders [17].
In terms of additional factors of influence, there is some evidence that sex both in the
parents and the offspring may play a role in the family transmission process. However, studies
diverge in findings by pointing to particular risks for either males or females, or no differences
between men and women (see [10]. Data from the WHO world mental health surveys [18]
indicate that males were more likely than females to have used drugs. In this large data-set, a
sex–cohort interaction was observed, whereby not only younger cohorts were more likely to
use all drugs, but the male–female gap was closing in more recent cohorts. In terms of age,
major surveys and reviews indicate that adolescence is the key period of development of SUD
[18, 19].
Furthermore, there has been a recent interest in potential risks for the development of men-
tal disorders in children stemming from parental age at birth in terms of both biological and
educational risks. Whereas advanced maternal age has been considered a reproductive risk as,
for instance, in the well-documented risk of increasing frequencies of Down syndrome chil-
dren, older paternal age has been hypothetically linked to an increased de novo mutations con-
tributing to the manifestation of schizophrenia [20, 21].
In addition, various studies point to the potential role that urbanization might have for the
development of mental disorders in the population. According to a recent review by Peen et al.
(2010) based on 20 population surveys, significant pooled urban–rural OR were found for the
total prevalence of psychiatric disorders, and for mood disorders and anxiety disorders. No
significant association with urbanization was found for substance use disorders. Finally, both
socioeconomic status and neighborhood deprivation have been identified as related risk fac-
tors of SUD in a large Swedish registry study [4].
This is another report from a series of matched, case-control, population-based analyses of
three-generation family aggregation and associated risk factors of various mental disorders
Family aggregation of substance use disorder
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[22–27]. In the present study, we apply this approach to the analysis of substance use disorders
(SUD). Specifically, we explore: (1) the family aggregation of SUD families with an affected
proband compared to families of controls without childhood or adolescence diagnoses, (2) the
effects of other mental disorders in the family members on case status with or without comor-
bid disorders, and (3) the association of age at first time diagnosis of depression with the family
load. To avoid confounding effects, (4) the analyses were controlled for the impact of sex, year
of birth, and degree of urbanization.
Materials and methods
The following descriptions in this section match the general outline of previous publications
based on the same study design that have focussed on disorders other than SUD [22–27]. The
text reproduces in part the information already provided in these previous publications.
Description of the dataset
The dataset of the present study contained N = 2504 case-probands with SUD, identified
through the Danish Psychiatric Central Research Registry (DPCRR) [28, 29]. The DPCRR con-
tains data on all individuals entering the public mental health system. From 1969 to 1994 only
inpatient admissions were registered whereas both in- and outpatient admissions have been
recorded since 1995. Only those born between 1st of April 1969 and 31st of December 1986
were included in the sample, which means the entire period of childhood and adolescence (0–
18 years) was covered by the end of the study period December 10, 2009 when the cohort had
a maximum age of 40 years. They had received an ICD-10 diagnosis [30] before age 18 and
had received SUD as a main diagnosis before the age of 40.
In Denmark, each individual is given an individual number at birth in the Danish Central
Civil Registration Register (DCR), thereby making it possible to cross-identify each person in
various other country-wide registers. In this way, for each case-proband, three control-pro-
bands were identified in the DCR, yielding a total of 7472 using risk-set sampling; that is, each
were alive and without registrations in the DPCRR at the time of case-proband ascertainment
during childhood and adolescence, and were matched to case-probands on age (same year and
month of birth), sex, and region of residence. Control-probands were excluded if they received
any psychiatric diagnosis before age 18 but included if they received any diagnosis after age 18.
Due to matching restrictions, not all case-probands had three control-counterparts for the
analyses to be reported. Collectively, the case-probands and control-participants are referred
to as probands.
Family members were identified through the DCR and DPCCR as previously described
[31]. Lifetime data were obtained from the first registration of any mental disorder and the
maximum period of observation for the diagnostic ascertainment of relatives via the DPCRR
was 40 years. Registry diagnoses of SUD were defined according to ICD-8 [32] criteria (code
303 and 304) until 1994, then, as of 1995, according to ICD-10 [30] criteria (code F1x). To
study the role of other mental disorders in the family aggregation, the following additional
diagnoses were also considered in the analyses: Bipolar disorders (BP, ICD-8 code 296; ICD-
10 code F30-31), depression (DEP, ICD-8 code 300.49; ICD-10 code F32-33 and 34.1), anxiety
disorders (ANX, ICD-8 code 300.0, 300.2; ICD-10 code F40, F41, F93.0–93.2), eating disorders
(ED, ICD-8 code 306.5; ICD-10 code F50), personality disorders (PERS, ICD-8 code 301;
ICD-10 code F60), and conduct disorder (ICD-8 code 308.1–308.2; ICD-10 code F90.1, 91,
92). Furthermore, the subgroups of SUD were defined as alcoholism (ALC, ICD-8 code 303;
ICD-10 code F10), abuse of opioids (ICD-8 code 304.09, 304.19; ICD-10 code F11), abuse of
cannabinoids (ICD-8 code 304.59; ICD-10 code F12), abuse of sedatives or hypnotics (ICD-8
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code 304.29, 304.39; ICD-10 code F13), abuse of cocaine (ICD-8 code 304.49; ICD-10 code
F14), abuse of stimulants (ICD-8 code 304.69; ICD-10 code F15) and abuse of hallucinogens
(ICD-8 code 304.79; ICD-10 code F16). Multiple SUD (MULT) was defined as ICD-10 code
F19 or when a person had two or more of the defined SUD diagnoses.
Statistical analyses
Chi-square tests were used to determine whether SUD occurred more often in the relatives of
case-probands compared to relatives of controls, and whether SUD was present more often in
families (i.e., when the family was treated as a single unit of analysis) of cases than in families
of controls. Effect sizes were assessed by Cramer‘s V for comparisons of frequencies of comor-
bid disorders. Coefficients ranging from 0 to 0.1 were considered very small, from 0.1 to 0.3
small, from 0.3 to 0.5 medium, and0.5 large.
Conditional logistic regression was applied to determine if the illness status of family members
increased the risk of the disease in the case-probands more strongly than in the control-probands.
The indicator variables examined were SUD and other mental disorders in family members. If data
from a family member were missing the value of the variable was 0, indicating the family member
was assumed to be unaffected. Since this method takes matching into account, the matched vari-
ables were not included in the analysis. All variables were included as categorical variables.
Multinomial logistic regression analysis was used for the comparison of risk factors origi-
nating from the various mental disorders in family members in three different groups: Case-
probands with SUD and any other mental disorders, case-probands with pure SUD (i.e. with-
out any comorbidity), and the group of control-probands without SUD. The group of control-
probands was used as the reference group, i.e. the presence of family disorders in both the
comorbid SUD group and the pure SUD group were compared to the controls. The risk was
measured as relative risk ratios (RRR).
Mixed logistic regression was used to estimate a family load measured as a random effect
showing the dependence among family members in relation to how often each family devel-
oped SUD. A model including a random effect is used when a dataset is divided into groups–
in this case into families. In the model, each family has its own intercept and the random effect
is the estimated standard deviation (SD) in the intercept on the logarithmic scale. For instance,
consider a mixed logistic regression model for a matched case-control study with families of
three generations which has a random effect of SD = 0.5. This means that members of a family
which is one standard deviation above the mean have the odds of getting SUD which are 65%
[since exp(0.5) = 1.65] higher than members of an average family.
The random effect was examined by group (namely, cases and controls) and was divided
for different age at diagnosis, namely up to 18 years, and age 18 or above at diagnosis of SUD
in the case-probands. Furthermore, the regression analysis included the matched explanatory
variables, i.e., sex, year of birth, month of birth, and region of residence at the index time of
the case-probands. In the analyses, the variable region of residence was defined as the hospital,
where the case-proband of the family received the first diagnosis. This value was copied to
all the case family-members and to the matched control families assuming that the case-pro-
band attended the nearest hospital and that the family members lived at the same place as the
proband, meaning the choice of hospital would reflect the region of residence. The variable
“region of residence” was converted into a dichotomous variable comparing the capital city of
Copenhagen to all other regions. Sex, month of birth, and region of residence were included as
categorical variables, while year of birth was included as a continuous variable.
Cox regression with shared frailty was applied to investigate whether case family members
had a greater risk over time of developing SUD than control family members, i.e. the probands
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were excluded from the analysis. A Cox model is a survival model and it is a function of the
hazard rate, which is the risk over time of experiencing a certain event such as SUD. A Cox
model with shared frailty includes a random effect named a frailty, which describes the effect
of unknown elements not included as parameters in the model. The family load component is
estimated as a random effect (frailty), i.e., it describes the dependence or lack of such between
the families of the study. The frailty does not vary within families, but rather between these.
The frailty is assumed to follow the gamma distribution with a mean value of 1 and variance θ.
The purpose of this approach is to estimate the effect of the explanatory variables while also
estimating θ.
Case status was included as a variable in the model in order to compare the risk of SUD
over time in case family members vs. control family members. The analysis also includes the
explanatory variables sex, year and month of birth, and region of residence, that were used in
the matching of the probands. The latter was converted into a dichotomous variable compar-
ing the capital of Copenhagen to all other regions. Sex, month of birth and region of residence
were included as categorical variables, whereas year of birth was included as a continuous vari-
able. All analyses were carried out by using the statistical software programs Stata version 13.1
[33] and R version 3.0.3 [34].
Results
Sample sizes, sex distributions, and the observation periods in the stratified case- and control
samples are shown in Table 1. In both case and control populations the maximum average
observational period was 40.69 years. For the case-probands, the mean observation time
amounted to 20.73 years. In the total group of N = 2504 case-probands there were N = 525
case-probands with a pure alcohol use disorder and N = 1285 case-probands with multiple
substance use disorders. In addition, there were N = 478 case-probands with pure cannabinoid
use disorder, and N = 39 case-probands with pure opioid use disorders. The remaining case-
probands were dispersed across the categories of abuse of pure sedatives or hypnotics
(N = 24), pure cocaine (N = 21), pure stimulants (N = 81), pure hallucinogens (N = 17), pure
Table 1. Demographic characteristics of the subjects.
N (%) Observation time in years*
Total Males Females Mean SD Range
Case families
Probands 2504 1513 (60.42) 991 (39.58) 20.73 4.70 12.37–39.76
Fathers 2406 2406 (100) 0 (0) 35.92 9.75 0.10–40.69
Mothers 2492 0 (0) 2492 (100) 37.67 7.89 0.27–40.69
Siblings 2488 1272 (51.13) 1216 (48.87) 28.50 8.16 0.00–40.69
Offspring 697 374 (53.66) 323 (46.34) 10.51 3.88 0.02–22.87
Total 10587 5565 (52.56) 5022 (47.44) 29.32 11.20 0.00–40.69
Control families
Probands 7472 4515 (60.43) 2957 (39.57) 29.34 4.98 12.14–40.69
Fathers 7330 7330 (100) 0 (0) 39.03 5.63 0.73–40.69
Mothers 7443 0 (0) 7443 (100) 39.91 3.79 1.11–40.69
Siblings 9991 5153 (51.58) 4838 (48.42) 28.71 8.00 0.00–40.69
Offspring 2095 1075 (51.31) 1020 (48.69) 9.43 3.50 0.00–23.06
Total 34331 18073 (52.64) 16258 (47.36) 32.31 9.72 0.00–40.69
*time from birth or 1st of April 1969 until date of first SUD diagnosis, date of death or end of study the 10th of December 2010
https://doi.org/10.1371/journal.pone.0177700.t001
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tobacco (N = 4), pure volatile solvents (N = 7), and unspecified drug dependency (N = 23).
Only the alcohol use disorders (ALC) and the multiple substance use disorders (MULT) were
considered for further sub-analyses because there were enough case-probands with affected
family members in these groups to investigate the family aggregation.
The frequencies of SUD in families of case and control-probands by class of relative in the
total group and in the two major subgroups of SUD are shown in Table 2. SUD was only
counted among case-parents and siblings if the diagnosis was given before the first SUD diag-
nosis in the case-proband of the family. For the control parents and siblings, the diagnosis was
given before the date of SUD of the matched case-proband. The SUD diagnosis for the off-
spring was also counted if it appeared after the SUD diagnosis of the case-proband. The odds
of case-proband family relatives having SUD in the total group were 5.96 times those for rela-
tives of control-probands, thus supporting the assumption of familial aggregation of SUD. The
differences were significant for parents and siblings. More specifically, the odds of SUD were
4.51 times higher in fathers of case-probands compared to fathers of control-probands, 7.69
times higher in mothers of case-probands compared to mothers of control-probands and 7.72
times higher in siblings of case-probands compared to siblings of control-probands. There
were too few offspring with SUD to say anything definite about the amount of SUD in cases
Table 2. The distribution of SUD and age at diagnosis in case and control families.
TOTAL
N(%)
ALC
N(%)
MULT
N(%)
SUD not present SUD present SUD not present SUD present SUD not present SUD present
Case families
Probands 0 (0.00) 2504 (100.00) 0 (0.00) 525 (100.00) 0 (0.00) 1285 (100.00)
Fathers 2114 (87.86) 292 (12.14) 470 (91.62) 43 (8.38) 1164 (95.02) 61 (4.98)
Mothers 2258 (90.61) 234 (9.39) 480 (91.78) 43 (8.22) 1218 (95.31) 60 (4.69)
Siblings 2415 (97.07) 73 (2.93) 541 (97.30) 15 (2.70) 1167 (93.96) 75 (6.04)
Offspring 694 (99.57) 3 (0.43) 212 (100.00) 0 (0.00) 307 (99.68) 1 (0.32)
Total 7481 (70.66) 3106 (29.34) 1703 (73.12) 626 (26.88) 3856 (72.24) 1482 (27.76)
Control families
Probands 7372 (98.66) 100 (1.34) 1564 (99.62) 6 (0.38) 3817 (99.45) 21 (0.55)
Fathers 7112 (97.03) 218 (2.97) 1490 (96.75) 50 (3.25) 3736 (99.28) 27 (0.72)
Mothers 7344 (98.67) 99 (1.33) 1543 (98.66) 21 (1.34) 3794 (99.32) 26 (0.68)
Siblings 9952 (99.61) 39 (0.39) 2101 (99.72) 6 (0.28) 5161 (99.59) 21 (0.41)
Offspring 2093 (99.90) 2 (0.10) 632 (100.00) 0 (0.00) 1014 (99.80) 2 (0.20)
Total 33873 (98.67) 458 (1.33) 7330 (98.88) 83 (1.12) 17522 (99.45) 97 (0.55)
OR 95% CI V1 OR 95% CI V1 OR 95% CI V1
Cases vs. controls
Fathers 4.51** 3.75–5.42 0.18 2.73** 1.79–4.16 0.11 7.25** 4.57–11.51 0.14
Mothers 7.69** 6.02–9.82 0.19 6.58** 3.84–11.30 0.17 7.19** 4.50–11.49 0.14
Siblings 7.72** 5.21–11.44 0.11 9.72** 3.73–25.32 0.11 15.78** 9.61–25.93 0.18
Offspring 4.52 0.75–27.15 0.03 - - - 1.65 0.15–18.28 0.01
Total 5.96** 5.20–6.82 0.16 4.44** 3.28–6.02 0.12 9.21** 7.03–12.06 0.15
1 Cramer’s V
* = p<0.05
** = p<0.001
https://doi.org/10.1371/journal.pone.0177700.t002
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compared to controls. All the effect sizes were very small to small on each level of the family
comparisons.
These findings were mirrored in the two subgroups ALC and MULT. For ALC, the odds of
case-proband family relatives having ALC before the date of ALC of the case-proband were
4.44 times those for relatives of control-probands, whereas for MULT, the odds of case-pro-
band family members having MULT before the date of MULT of the case-proband were
9.21 times those of control-probands. Thus, the family aggregation of SUD in total was also
reflected in the two major subgroups ALC and MULT. As Table 2 shows, the odds of ALC and
MULT were significantly higher among fathers, mothers, and siblings of case-probands com-
pared to family members of control-probands. As in the total SUD sample, the effect sizes
again were very small to small on each level of the family comparisons in the ALC and MULT
subgroups.
As Table 3 shows, the vast majority of case-probands had comorbid disorders, most com-
mon was PERS followed by DEP, CD, and ANX and less frequently by ED and BP. Informa-
tion on the frequencies of the six co-morbid disorders by class of relative across the case and
control-families and the subgroups is provided in Table 4. Again, diagnoses among case-
parents and siblings were only counted if a diagnosis was given before the SUD diagnosis in
the case-proband of the family, and for the control-parents and siblings the diagnosis had to
be given before the date of SUD of the matched case-proband. The diagnoses for the offspring
were counted also if they appeared after the SUD diagnosis of the case-proband.
In the total SUD sample, DEP, ANX, and PERS were significantly more common in all rela-
tives of case-probands, except the offspring compared to the relatives of control-probands.
Furthermore, BD were significantly more common in parents of case-probands compared to
the parents of controls, ED were significantly more common in mothers and siblings of case-
probands compared to the controls, and CD were significantly more common in siblings and
offspring of case-probands compared to the controls. In terms of the effect sizes, all associa-
tions were in the very small to small range.
Subsequent analyses in the two subgroups with either ALC or MULT showed mostly simi-
lar findings. In contrast to the comparisons in the total SUD sample, Fishers exact tests
between case and control family members in the ALC subgroup showed no significant differ-
ences for parents with bipolar disorders whereas more case siblings than control siblings had
bipolar disorders. Also, the differences between the number of case and control fathers with
depression or anxiety disorders and the differences between the number of case and control
siblings with anxiety disorders or eating disorders were no longer significant in the ALC sub-
group, most likely due to the smaller sample size making the detection of differences more
Table 3. Comorbid diagnoses among case and control-probands.
N(%)
Cases Controls
Probands with pure SUD 250 (9.98) 26 (0.35)
Probands with comorbid SUD 2254 (90.02) 74 (0.99)
Comorbid disorders among probands with SUD
BP 101 (4.48) 4 (5.41)
DEP 539 (23.91) 28 (37.84)
ANX 293 (13.00) 10 (13.51)
ED 171 (7.59) 1 (1.35)
PERS 1195 (53.02) 14 (18.92)
CD 350 (15.53) 0 (0.00)
https://doi.org/10.1371/journal.pone.0177700.t003
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difficult. In the ALC group there was also no significant differences between the total number
of family members with eating disorders in case vs. control families. The respective
Table 4. The distribution of comorbid disorders in case and control families.
TOTAL
N (%)
ALC
N (%)
MULT
N (%)
Case
families
Control
families
V1 Case
families
Control
families
V1 Case
families
Control
families
V1
BP
Fathers 27 (1.12) 47 (0.64) 0.02* 6 (1.17) 10 (0.65) 0.03 15 (1.22) 30 (0.80) 0.02
Mothers 49 (1.97) 57 (0.77) 0.05** 11 (2.10) 16 (1.02) 0.04 28 (2.19) 25 (0.65) 0.07**
Siblings 5 (0.20) 9 (0.09) 0.01 4 (0.72) 3 (0.14) 0.05* 1 (0.08) 5 (0.10) 0.00
Offspring 0 (0.00) 0 (0.00) - 0 (0.00) 0 (0.00) - 0 (0.00) 0 (0.00) -
Total 81 (1.00) 113 (0.42) 0.03** 21 (1.16) 29 (0.50) 0.04* 44 (1.09) 60 (0.44) 0.04**
DEP
Fathers 52 (2.16) 77 (1.05) 0.04** 9 (1.75) 16 (1.04) 0.03 28 (2.29) 47 (1.25) 0.04*
Mothers 120 (4.82) 113 (1.52) 0.09** 24 (4.59) 27 (1.73) 0.08* 52 (4.07) 58 (1.52) 0.08**
Siblings 54 (2.17) 54 (0.54) 0.07** 12 (2.16) 20 (0.95) 0.05* 30 (2.42) 22 (0.42) 0.09**
Offspring 1 (0.14) 5 (0.24) 0.01 0 (0.00) 2 (0.32) 0.03 0 (0.00) 2 (0.20) 0.02
Total 227 (2.81) 249 (0.93) 0.07** 45 (2.49) 65 (1.11) 0.05** 110 (2.71) 129 (0.94) 0.06**
ANX
Fathers 26 (1.08) 28 (0.38) 0.04** 4 (0.78) 6 (0.39) 0.02 14 (1.14) 14 (0.37) 0.04*
Mothers 98 (3.93) 82 (1.10) 0.09** 23 (4.40) 21 (1.34) 0.09** 50 (3.91) 38 (0.99) 0.10**
Siblings 21 (0.84) 26 (0.26) 0.04** 4 (0.72) 5 (0.24) 0.03 12 (0.97) 15 (0.29) 0.04*
Offspring 2 (0.29) 3 (0.14) 0.01 0 (0.00) 1 (0.16) 0.02 1 (0.32) 1 (0.10) 0.02
Total 147 (1.82) 139 (0.52) 0.06** 31 (1.72) 33 (0.56) 0.05** 77 (1.90) 68 (0.49) 0.07**
ED
Fathers 0 (0.00) 0 (0.00) - 0 (0.00) 0 (0.00) - 0 (0.00) 0 (0.00) -
Mothers 9 (0.36) 8 (0.11) 0.03* 3 (0.57) 0 (0.00) 0.07* 6 (0.47) 6 (0.16) 0.03
Siblings 19 (0.76) 30 (0.30) 0.03* 2 (0.36) 7 (0.33) 0.00 12 (0.97) 13 (0.25) 0.05*
Offspring 2 (0.29) 3 (0.14) 0.01 2 (0.94) 1 (0.16) 0.06 0 (0.00) 2 (0.20) 0.02
Total 30 (0.37) 41 (0.15) 0.02** 7 (0.39) 8 (0.14) 0.02 18 (0.44) 21 (0.15) 0.03*
PERS
Fathers 191 (7.94) 147 (2.01) 0.14** 32 (6.24) 31 (2.01) 0.11** 115 (9.39) 76 (2.02) 0.17**
Mothers 288 (11.56) 153 (2.06) 0.20** 60 (11.47) 39 (2.49) 0.18** 155 (12.13) 80 (2.09) 0.21**
Siblings 90 (3.62) 70 (0.70) 0.10** 24 (4.32) 19 (0.90) 0.11** 50 (4.03) 34 (0.66) 0.12**
Offspring 3 (0.43) 4 (0.19) 0.02 3 (1.42) 1 (0.16) 0.08 0 (0.00) 2 (0.20) 0.02
Total 572 (7.08) 374 (1.39) 0.15** 119 (6.60) 90 (1.54) 0.13** 320 (7.90) 192 (1.39) 0.16**
CD
Fathers 0 (0.00) 2 (0.03) 0.01 0 (0.00) 0 (0.00) - 0 (0.00) 0 (0.00) -
Mothers 0 (0.00) 0 (0.00) - 0 (0.00) 0 (0.00) - 0 (0.00) 0 (0.00) -
Siblings 23 (0.92) 16 (0.16) 0.05** 6 (1.08) 3 (0.14) 0.07* 16 (1.29) 10 (0.19) 0.07**
Offspring 16 (2.30) 7 (0.33) 0.09** 3 (1.42) 0 (0.00) 0.10* 9 (2.92) 6 (0.59) 0.09*
Total 39 (0.48) 25 (0.09) 0.04** 9 (0.50) 3 (0.05) 0.05** 25 (0.62) 16 (0.12) 0.04**
Fishers exact test
* = p<0.05
** = p<0.001
1 Cramer’s V
https://doi.org/10.1371/journal.pone.0177700.t004
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comparisons in the MULT subgroup also revealed no significant differences for fathers with
bipolar disorders and mothers with eating disorders.
Findings from the conditional logistic regression analysis determining the association of SUD,
ALC, or MULT in case-probands vs. control-probands with either SUD or other mental disorders
in family members are illustrated in Fig 1. As in the previous analyses, SUD was only counted in
parents and siblings if it appeared before the SUD diagnosis of the case-proband. Compared to
the control- probands, in the total sample SUD in the case-probands was significantly associated
with SUD (OR = 3.76, p<0.001, 95% CI = 3.16–4.49), DEP (OR = 1.51, p<0.001, 95% CI = 1.20–
1.89), ANX (OR = 1.66, p<0.001, 95% CI = 1.26–2.19), PERS (OR = 2.76, p<0.001, 95% CI =
2.31–3.30), and CD (OR = 3.55, p<0.001, 95% CI = 2.04–6.20) but not with BP (OR = 0.92, p = n.
s., 95% CI = 0.65–1.29) and ED (OR = 1.14, p = n.s., 95% CI = 0.66–1.99) in family members.
In the ALC subgroup, the associations with SUD (only ALC was counted; OR = 3.30,
p<0.001, 95% CI = 2.28–4.76), PERS (OR = 3.08, p<0.001, 95% CI = 2.17–4.39) and CD
(OR = 8.87, p<0.05, 95% CI = 2.30–34.18) were significant, whereas BP (OR = 1.23, p = n.s.,
95% CI = 0.64–2.39), DEP (OR = 1.29, p = n.s., 95% CI = 0.81–2.05), ANX (OR = 1.58, p = n.
s., 95% CI = 0.90–2.79) and ED (OR = 1.59, p = n.s., 95% CI = 0.48–5.31) were not. The confi-
dence intervals for CD in the ALC group were rather wide as very few family members in this
Fig 1. Associations of SUD in the case-probands versus the control-probands with SUD and other mental SUDs in first-degree
family members in the total sample and the pure alcohol (ALC) and the multiple (MULT) substance use disorders. SUD =
Substance use disorders; BD = Bipolar disorders; DEP = Depression; ANX = Anxiety disorders; ED = Eating disorders; PERS = Personality
disorders; CD = Conduct disorders.
https://doi.org/10.1371/journal.pone.0177700.g001
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group had CD, making the result less precise. There were significant associations with SUD in
the MULT subgroup (only MULT was counted; OR = 4.54, p<0.001, 95% CI = 3.28–6.30),
ANX (OR = 1.82, p<0.05, 95% CI = 1.23–2.68), PERS (OR = 3.52, p<0.001, 95% CI = 2.78–
4.45) and CD (OR = 3.79, p<0.001, 95% CI = 1.83–7.87), whereas BP (OR = 1.00, p = n.s., 95%
CI = 0.63–1.59), DEP (OR = 1.25, p = n.s., 95% CI = 0.90–1.75) and ED (OR = 1.08, p = n.s.,
95% CI = 0.51–2.28) were not significant.
Table 5 shows the results of multinomial logistic regression considering SUD as a comorbid
condition (N = 2254) in the case-probands vs. a pure condition without any further comorbid-
ity (N = 250), where the controls without SUD are the reference group. In this analysis, paren-
tal age at birth of the proband and the presence of SUD and other mental disorders in family
members served as risk factors, and the model was adjusted for the matched variables. Both
family SUD and the variable marking other mental disorders among family-members were
measured by binary variables with a value of 1 if a disorder was present before the date of SUD
of the case-proband and otherwise zero. These analyses were performed only for the total SUD
group because both in the ALC and in the MULT subgroup the number of individuals with a
non-comorbid pure SUD diagnosis were too small for reliable analyses.
The results demonstrated that if at least one family member had SUD, then the relative risk
for a case-proband getting comorbid SUD was expected to increase by a factor of 4.62 com-
pared to the controls, given the other variables in the model were held constant. The results
also showed that if a family member had SUD, then the relative risk for a case-proband getting
pure SUD was expected to increase by a factor of 4.90 compared to the controls, given the
other variables in the model were held constant. A Wald test was performed to test whether or
not the effect of family SUD in predicting comorbid SUD among case-probands vs. controls-
probands equals the effect of family SUD in predicting pure SUD among case-probands vs.
control-probands. The test showed that the effects were not statistically different from each
other (χ2 = 0.06, p = 0.81).
In the same way, the effect of one or more of the diagnoses BP, DEP, ANX, ED, PERS or
CD in the family was studied. A Wald test showed that the effect of one or more of the diagno-
ses BP, DEP, ANX, ED, PERS or CD in the family members in predicting comorbid SUD
among case- probands vs. controls-probands was statistically different (χ2 = 9.71, p<0.05)
from the effect of one or more of the defined diagnoses in the family members in predicting
pure SUD among case-probands vs. control-probands.
An interaction term was included in the model in order to test the extra effect of having
both SUD and one or more of the diagnoses BP, DEP, ANX, ED, PERS or CD in the family-
members. In the group of case-probands with comorbid SUD, the exponential coefficient for
the interaction was 0.64. This means that that if SUD and one or more of the diagnoses BP,
DEP, ANX, ED, PERS or CD were present in a family, then the relative risk of the case-pro-
band getting comorbid SUD was expected to increase by a factor of 4.623.190.64 = 9.43 com-
pared to the controls, given the other variables in the model were held constant. In the same
way, if both SUD and one or more of the other defined disorders were present in a family, the
relative risk for the case-proband getting pure SUD was expected to increase by a factor of
4.901.510.32 = 2.37 compared to the controls, if the other variables in the model are held
constant. A Wald test showed that the effect of the interaction in predicting comorbid SUD
among case-probands vs. control-probands was not significantly different (χ2 = 2.34, p = 0.13)
from the effect of the interaction in predicting pure SUD among case-probands vs. control-
probands.
Table 6 shows the results of mixed logistic regression, which has the purpose of estimating
the family load. The matched variables were included in order to take the matching into
account. Male sex, and more recent year of birth were significant additional risk factors in the
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total group and in the ALC and MULT subgroups whereas living in the capital city of Copen-
hagen was a significant additional risk factor only in the total and the MULT groups. Being
born in August, September, October or November also had significant p-values in the total
group, but the confidence intervals were very close to, 1 and had a range almost similar to the
Table 5. Multinomial logistic regression with three groups of probands as the outcome variable
(case-probands having either comorbid or pure SUD and SUD-free controls as the reference group).
The model is adjusted for the matched variables.
RRR SE P 95% CI
Controls Reference
group
Comorbid SUD
Maternal age at birth
Age<35 Reference
Age35 0.89 0.10 n.s. 0.71–
1.12
Paternal age at birth
Age<35 Reference
Age35 1.05 0.08 n.s. 0.91–
1.21
Family SUD
No Reference
Yes 4.62 0.57 <0.001 3.63–
5.88
Family BP, DEP, ANX, ED, PERS or CD
No Reference
Yes 3.19 0.25 <0.001 2.73–
3.71
Interaction between family SUD and family BP, DEP, ANX, ED, PERS or
CD
0.64 0.11 <0.05 0.46–
0.90
Pure SUD
Maternal age at birth
Age<35 Reference
Age35 0.67 0.22 n.s. 0.35–
1.30
Paternal age at birth
Age<35 Reference
Age35 0.94 0.18 n.s. 0.64–
1.37
Family SUD
No Reference
Yes 4.90 1.21 <0.001 3.02–
7.96
Family BP, DEP, ANX, ED, PERS or CD
No Reference
Yes 1.51 0.36 n.s. 0.95–
2.40
Interaction between family SUD and family BP, DEP, ANX, ED, PERS or
CD
0.32 0.15 <0.05 0.13–
0.78
RRR = Relative risk ratio (the exponentiated coefficients from the multinomial logistic regression model);
SUD = Substance Use Disorders
https://doi.org/10.1371/journal.pone.0177700.t005
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confidence intervals for the other non-significant months of birth. Thus, the results do not
necessarily indicate that being born in these months is any riskier than being born in January
(the reference group). The random effect contributed with 30 percent of the total variance in
the total group and a likelihood-ratio test of a contribution to variance equal to zero showed
that a model with a random effect explained more of the data than a model without a random
effect (χ2 = 443.23, p<0.001). The random effect contributed to 19% of the total variance in
the ALC group, and 27% in the MULT group. A likelihood-ratio test of a contribution to vari-
ance equal to zero showed that that a model with a random effect explained more of the data
than a model without a random effect in both the ALC and the MULT subgroups (ALC: χ2 =
32.54, p<0.001; MULT: χ2 = 141.79, p<0.001).
The box plot in Fig 2 displays the family load components estimated based on the mixed logis-
tic regression model from Table 6. Year of birth, month of birth, sex and region of residence
made up the fixed effects of the mixed logistic regression model, while the random effect reflected
the correlation between family members, i.e. the risk level of SUD for each family. The family
load was defined as the random effect which is shown in Fig 2. It can be seen that in both the
total sample and in the ALC and MULT subgroups case families had a significantly higher family
load component than control families meaning that family aggregation explains a larger part of
the variance in case families than in control families. The two-sample Wilcoxon rank-sum test
Table 6. Mixed logistic regression with the purpose of estimating the family load, which is measured as a random effect.
TOTAL ALC MULT
OR SE 95% CI OR SE 95% CI OR SE 95% CI
Sex
Female 1.00 Reference 1.00 Reference 1.00 Reference
Male 1.57** 0.06 1.45–1.69 1.30* 0.11 1.10–1.53 1.59** 0.09 1.42–1.79
Month of birth
January 1.00 Reference 1.00 Reference 1.00 Reference
February 0.96 0.10 0.79–1.18 0.87 0.19 0.57–1.33 0.99 0.14 0.74–1.32
March 1.00 0.10 0.83–1.22 0.95 0.20 0.63–1.44 0.87 0.13 0.66–1.15
April 1.03 0.10 0.85–1.25 1.14 0.22 0.78–1.68 0.87 0.13 0.66–1.16
May 1.13 0.11 0.93–1.36 1.16 0.23 0.78–1.71 0.98 0.14 0.74–1.29
June 1.15 0.11 0.95–1.39 1.05 0.22 0.70–1.58 0.94 0.13 0.71–1.25
July 1.09 0.11 0.90–1.31 1.16 0.23 0.78–1.71 0.97 0.14 0.74–1.28
August 1.22* 0.12 1.01–1.47 1.10 0.23 0.73–1.66 1.11 0.15 0.84–1.45
September 1.22* 0.12 1.01–1.48 1.10 0.22 0.74–1.64 1.13 0.16 0.86–1.48
October 1.25* 0.12 1.04–1.51 1.12 0.23 0.74–1.69 1.06 0.15 0.80–1.40
November 1.27* 0.12 1.05–1.54 0.91 0.20 0.58–1.40 1.33* 0.18 1.02–1.75
December 1.21 0.12 1.00–1.47 0.98 0.21 0.65–1.49 1.13 0.16 0.85–1.49
Year of birth 1.02** 0.00 1.02–1.02 1.02** 0.00 1.01–1.02 1.04** 0.00 1.04–1.04
Region of residence
City of Copenhagen 1.00 Reference 1.00 Reference 1.00 Reference
Other regions 0.87* 0.04 0.79–0.97 0.90 0.09 0.74–1.09 0.85* 0.06 0.73–0.98
RE SE 95% CI RE SE 95% CI RE SE 95% CI
Standard deviation 1.18 0.04 1.10–1.26 0.87 0.09 0.70–1.07 1.12 0.06 1.00–1.25
Contribution to variance 0.30 0.01 0.27–0.32 0.19 0.03 0.13–0.26 0.27 0.02 0.23–0.32
* = p<0.05
** = p<0.001
RE = random effect results
https://doi.org/10.1371/journal.pone.0177700.t006
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for testing the family load among males and females separate for the case and the control-pro-
bands showed that in the total sample there were significant differences in the family load
between males and females among both cases and control-probands, with a higher load in
females (Cases: Females N = 991, rank sum = 1301192, expected = 1241227.5 vs. males N = 1513,
rank sum = 1835068, expected = 1895032.5; z = 3.39, p<0.001. Controls: Females N = 2957, rank
sum = 11855517, expected = 11048831 vs. males N = 4515, rank sum = 16063611, expected =
16870298; z = 8.85, p<0.001).
The same test in the ALC subgroup showed no significant differences in the family load
between male and female probands in both the case and the control group (Cases: Females
N = 235, rank sum = 61214, expected = 61805 vs. males N = 290, rank sum = 76861, expected =
76270; z = -0.34, p = 0.73. Controls: Females N = 704, rank sum = 568237, expected = 552992
vs. males N = 866, rank sum = 664998, expected = 680243; z = 1.71, p = 0.09). In the MULT
subgroup, the two-sample Wilcoxon rank-sum test had a result similar to the result in the
total SUD sample, i.e. a significantly higher load in females (Cases: Females N = 481, rank
sum = 329788.5, expected = 309283 vs. males N = 804, rank sum = 496466.5, expected = 516972;
z = 3.19, p<0.05. Controls: Females N = 1436, rank sum = 2939918, expected = 2756402 vs.
males N = 2402, rank sum = 4427123, expected = 4610639; z = 5.52, p<0.001).
Fig 2. Family load components in case-probands by age at diagnosis and controls in the total sample and the pure alcohol
(ALC) and the multiple (MULT) substance use disorders.
https://doi.org/10.1371/journal.pone.0177700.g002
Family aggregation of substance use disorder
PLOS ONE | https://doi.org/10.1371/journal.pone.0177700 May 17, 2017 13 / 19
The two-sample Wilcoxon rank-sum test was also used to test whether there was a difference
between the family load of case-probands with the diagnosis of SUD before age 18 vs. case-pro-
bands with the diagnosis of SUD at age 18 or later but before the end of the study. The test dem-
onstrated a significantly higher load in cases with diagnosis at or after age 18 (diagnosis of SUD
before age 18: N = 1032, rank sum = 1176391.5, expected = 1292580 vs. diagnosis of SUD at age
18 or later: N = 1472, rank sum = 1959868.5, expected = 1843680; z = -6.53, p<0.001). The
same test in the subgroup ALC also showed a significantly higher load in cases with diagnosis at
or after age 18 (diagnosis of SUD before age 18: N = 188, rank sum = 44623, expected = 49444
vs. diagnosis of SUD at age 18 or later: N = 337, rank sum = 93452, expected = 88631; z = -2.89,
p<0.05), whereas the test in the subgroup MULT did not show any significant differences (diag-
nosis of SUD before age 18: N = 526, rank sum = 333230.5, expected = 338218 vs. diagnosis of
SUD at age 18 or later: N = 759, rank sum = 493024.5, expected = 488037; z = -0.762, p = 0.446).
The question of whether or not case family members had a greater risk over time of devel-
oping SUD than control family members was investigated using Cox regression with shared
frailty. As described above, this method estimates the family load component as a random
effect in a similar way to mixed logistic regression. However, in this analysis the family load
component (frailty) is estimated in relation to the time of SUD diagnosis. All individuals were
followed from birth or April 1 1969 until date of diagnosis of SUD, date of death, or December
10 2009 where, data was censored if SUD or death had not occurred. Findings are shown in
Table 7. The case status was included as a variable, which showed that case-family members
were 6.36 times as likely as control family members to develop any SUD diagnosis over time
(Hazard ratio (HR) = 6.36, p<0.001, 95% CI = 5.50–7.36). The results in the total sample also
indicated that year of birth and males were significant. The hazard ratio (HR) showed, that
being male (HR = 1.70, p<0.001, 95% CI = 1.49–1.94) was a risk factor, but that living outside
of Copenhagen lowered the risk (HR = 0.74, p<0.001, 95% CI = 0.63–0.87). Later year of birth
i.e. younger age (HR = 0.98, p<0.001, 95% CI = 0.97–0.99) also lowered the risk, but only very
little. Furthermore, birth in August (HR = 1.42, p<0.05, 95% CI = 1.02–1.99) or September
(HR = 1.51, p<0.05, 95% CI = 1.08–2.10) also had significant p-values, but the 95% confidence
intervals for these two months were close to 1 and very similar to the confidence intervals for
the other non-significant months, which indicated that it was no riskier to be born in August
or September compared to January. The variance of the frailty was 1.96, which was not signifi-
cant, i.e. the risk level of SUD in each family was almost explained by the included variables,
which leaves no significant effect from unknown variables.
In the ALC subgroup, the Cox model with shared frailty showed that case family members
were 4.58 times as likely as control family members to develop ALC over time (Hazard ratio
(HR) = 4.58, p<0.001, 95% CI = 3.34–6.30). The model also showed that being male (HR =
1.56, p<0.05, 95% CI = 1.15–2.12) was a risk factor. The variance of the random effect was
1.18, which was not significant. The Cox model for the MULT subgroup showed that case
family members were 10.32 times as likely as control family members to develop MULT over
time (Hazard ratio (HR) = 10.32, p<0.001, 95% CI = 7.75–13.74). Furthermore, later year of
birth (HR = 1.03, p<0.001, 95% CI = 1.02–1.05) and being male (HR = 1.63, p<0.001, 95%
CI = 1.27–2.09) were risk factors, but living outside of Copenhagen (HR = 0.51, p<0.001,
95% CI = 0.38–0.69) lowered the risk. The variance of the random effect was 2.63 and not
significant.
Discussion
The first major finding of the present study was that SUD occurred more often in relatives of
case- probands than in relatives of controls; statistically higher proportions of affliction were
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observed in fathers, mothers, and siblings. In particular, case-family members were more than
six times as likely as control family members to develop any SUD diagnosis over time. This
finding of a high family aggregation of SUD is very much in line with prior evidence of family
transmission reported in both clinical samples [1–3, 7] and large registry studies [4–6].
The findings also corroborate the relevance of comorbid disorders on various levels. First,
the large majority of case-probands had comorbid disorders with mostly PERS followed by
DEP, CD, and ANX, and less frequently by ED and BP. These findings are in accordance with
previous studies based on clinical samples pointing to the co-occurrence of SUD with ANX or
DEP [8, 11] eating disorders [15, 16] and externalizing disorders including CD [12, 17] but
also with our previous studies using the same study design on ED [26] and phobic disorders
[27].
In addition, the study also underlined the major role that comorbid disorders in other fam-
ily members play in the transmission process. Having family members affected by DEP, ANX,
PERS, or CD increased the risk of SUD in the case-probands. These findings based on a large
national dataset corroborate those from other family studies indicating high rates of, for exam-
ple, comorbid anxiety disorders among parents with SUD [13]; but also point to a more wide-
spread relevance of further major mental disorders in the families of case-probands with SUD.
In the family transmission process, both SUD per se and comorbid disorders in the family
members played an eminent role. The contribution of family SUD was highly relevant
Table 7. Cox regression with shared frailty considering the time to diagnosis of SUD.
TOTAL ALC MULT
HR p 95% CI HR p 95% CI HR p 95% CI
Case/Control status
Control 1.00 Reference 1.00 Reference 1.00 Reference
Case 6.36 <0.001 5.50–7.36 4.58 <0.001 3.34–6.30 10.32 <0.001 7.75–13.74
Sex
Female 1.00 Reference 1.00 Reference 1.00 Reference
Male 1.70 <0.001 1.49–1.94 1.56 <0.05 1.15–2.12 1.63 <0.001 1.27–2.09
Month of birth
January 1.00 Reference 1.00 Reference 1.00 Reference
February 1.07 n.s. 0.75–1.53 1.06 n.s. 0.47–2.38 0.91 n.s. 0.48–1.72
March 1.26 n.s. 0.90–1.76 1.11 n.s. 0.51–2.45 0.78 n.s. 0.42–1.46
April 1.14 n.s. 0.81–1.61 1.33 n.s. 0.62–2.88 0.75 n.s. 0.40–1.40
May 1.21 n.s. 0.86–1.70 1.81 n.s. 0.86–3.81 0.91 n.s. 0.50–1.67
June 1.14 n.s. 0.80–1.61 1.19 n.s. 0.52–2.71 0.84 n.s. 0.44–1.62
July 1.02 n.s. 0.71–1.45 0.86 n.s. 0.36–2.06 0.89 n.s. 0.48–1.66
August 1.42 <0.05 1.02–1.99 1.52 n.s. 0.70–3.28 1.55 n.s. 0.87–2.75
September 1.51 <0.05 1.08–2.10 1.43 n.s. 0.66–3.09 1.49 n.s. 0.84–2.63
October 1.21 n.s. 0.86–1.71 1.45 n.s. 0.67–3.17 1.00 n.s. 0.54–1.86
November 1.15 n.s. 0.81–1.64 0.74 n.s. 0.29–1.86 1.27 n.s. 0.69–2.33
December 1.32 n.s. 0.94–1.85 1.07 n.s. 0.47–2.43 1.27 n.s. 0.69–2.31
Year of birth 0.98 <0.001 0.97–0.99 1.01 n.s. 0.99–1.02 1.03 <0.001 1.02–1.05
Region of residence
City of Copenhagen 1.00 Reference 1.00 Reference 1.00 Reference
Other regions 0.74 <0.001 0.63–0.87 0.80 n.s. 0.57–1.12 0.51 <0.001 0.38–0.69
Variance of frailty 1.96 n.s. 1.18 n.s. 2.63 n.s.
HR = Hazard ratio
https://doi.org/10.1371/journal.pone.0177700.t007
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irrespective of the case-proband showing pure or comorbid SUD. In both associations the
RRR was high and of similar magnitude.
The analyses as to the transmission of comorbid disorders shows that if comorbid disorders
were present in a family, then the case-proband was more likely to have comorbid SUD rather
than pure SUD. The analyses also showed that the presence of both SUD and one or more of
the diagnoses BP, DEP, ANX, ED, PERS, or CD in a family member actually lowered the risk
of SUD in the case-probands, compared to what one would expect when looking at the sepa-
rate risks of SUD in the family and one or more comorbid disorders in the family. This is
because the interaction term was less than one in both the group of case-probands with pure
SUD and in the group of case-probands with comorbid SUD. These different patterns of fam-
ily aggregation have not been identified before as previous family studies have only studied
comorbid disorders in isolation.
In addition to the family effects, the present study showed the effect of both further risk and
protective factors. Both advanced maternal or paternal age (35 years) had no significant
effect in the present study. The recognition of these markers of both a biological and an edu-
cational risk as significant risk factors for the development of offspring disorders has been
inconsistent in our family studies that have used the same overall study design in terms of an
advanced paternal age in case-probands with schizophrenia [22] and an advanced maternal
age in case-probands with obsessive-compulsive disorders [25]. Whereas a recent Swedish
registry study found that an even higher paternal age (45+) was associated with increased risk
of psychiatric and academic morbidity, including substance use problems in the offspring
[21]. In contrast, male sex was a clear risk factor supporting the findings from most epidemio-
logical surveys [18, 19]. Furthermore, the year of birth effect was too small to derive any solid
conclusion.
Furthermore, there was a difference between the family load of case-probands with the
diagnosis of SUD before age 18 vs. case-probands with the diagnosis of SUD at age 18 or later
but before the end of the study. Both in the total group and in the ALC, but not in the MULT
subgroup, the family load was higher in case-probands with a higher age at diagnosis of SUD.
Thus, these findings lend no support to the vulnerability hypothesis in neurodevelopmental
disorders that suggests that higher family loads of mental disorders contribute to an earlier
manifestation of the respective disorder in the offspring. Such a higher family liability has, for
instance, been put forward for schizophrenia but has not been observed in our own respective
study [22].
Finally, the finding of a significant urbanization effect with an increased risk of living in the
capital for the manifestation of SUD stands in line with findings from two our two previous
studies using the same study design in case-probands affected by schizophrenia [22] or by
ANX [24]. However, it is in contrast to no significant effects in case-probands with either BD
[23], or obsessive-compulsive disorders [25], or ED [26], or phobic disorders [27]. Thus, there
is no consistent pattern of findings on urbanization effects in this series of family studies. Simi-
lar mixed findings contributing to a meta-analysis of urban-rural differences in the prevalence
of psychiatric disorders in population studies may have led to the overall finding of no urbani-
zation effects for SUD [35].
However, after considering the various additional explanatory variables, the analyses indi-
cated that the family load estimate explained 30 percent of the variance of the family aggrega-
tion of SUD, therefore implicating other important factors like co-morbid disorders in the
etiology of the disease. This finding has to be considered in perspective with our other family
aggregation studies that revealed a 23% rate of explained variance in schizophrenia [22], a 20%
rate in bipolar disorders [23], a 12% rate in anxiety disorders [24], a 6% rate in obsessive com-
pulsive disorders [25], but an almost zero effect in ED [26] and phobic disorders [27]. Thus,
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there is clear evidence that family load is higher in SUD in comparison to a large number of
major psychiatric disorders. This reflects the strong effects of both genetic and environmental
risk factors. Among the latter, socioeconomic status and neighborhood deprivation in particu-
lar, have been identified as risk factors of drug abuse in a large Swedish registry study [4].
Besides analyzing family aggregation and risk factors for developing SUD in the unselected
total group, the two major subgroups of ALC and MULT were considered separately. By and
large, the findings were identical or similar in these two subgroups. These findings highlight
general risk factors of SUD rather than any drug-specific associations. However, it should be
noted that the relatively large group of pure cannabinoid abusers among the case-probands
was not suitable for analysis due to a relatively low family aggregation that may have been due
to the fact that cannabinoid use had not yet been sufficiently prevalent in the parental genera-
tion. Furthermore, the rather small group of pure opioid abusers did not allow for separate
analyses of these pure effects. However, both cannabinoid and opioid effects contributed to
the effects observed in the MULT subgroup.
The finding of mostly lacking evidence of drug-specific associations stands in contrast to
some previous studies based on smaller and less representative samples. For instance, the Col-
laborative Study on the Genetics of Alcoholism revealed evidence of both common and spe-
cific addictive factors transmitted in families for alcohol, marijuana, and cocaine dependence
and habitual smoking and suggested independent causative factors in the development of each
type of substance dependence [3]. Likewise, in a much smaller clinical cohort there was also
evidence of specificity of familial aggregation of the predominant drug of abuse [7].
Advantages of the study include surveillance of a large population sample, an extended
period of observation, a data set covering three generations and the matching of cases and con-
trols on potentially confounding variables. There are several limitations. First, cases of illness
for which treatment was not sought, or treated privately (although private care is uncommon
in Denmark) were not included in the analysis. Secondly, there is no independent verification
of the accuracy of diagnoses entered in the DCPRR, although prior quality checks on the
DCPRR suggest that diagnostic validity is high across a range of disorders [36–39]. Thirdly,
given that mental disorders in the data set are determined by treatment seeking, it can be
assumed that many cases of familial illness remain “undetected,” and this may pertain to SUD
as well. On the other hand, having a mentally ill relative might have increased the chance of
seeking professional assistance and thus, the chance of registration rather than the risk of
developing SUD. Fourthly, the rather late registration of outpatients in the DCPRR since 1995
may have resulted in an under-representation of the true number of patients with SUD.
Finally, in the analyses the region of residence could only be defined as the hospital in which
the case-probands received their first diagnosis.
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